BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Müller-Redetzky H, Lienau J, Suttorp N, Witzenrath M. Therapeutic strategies in pneumonia: going beyond antibiotics. Eur Respir Rev 2015;24:516-24. [PMID: 26324814 DOI: 10.1183/16000617.0034-2015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Trivedi J, Shaikh J, Chavan N, Thorve D, Chaudhary B, Karade A, Gupta S, Patel A, Bhagwat S. Pretreatment of nafithromycin attenuates inflammatory response in murine lipopolysaccharide induced acute lung injury. Cytokine 2020;129:155049. [PMID: 32126500 DOI: 10.1016/j.cyto.2020.155049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Upadhyay M, Nehme A, Wasnik S. Title-Inflammatory Signaling Pathways in Allergic and Infection-Associated Lung Diseases. Allergies 2022;2:57-74. [DOI: 10.3390/allergies2020006] [Reference Citation Analysis]
3 Witzenrath M, Kuebler WM. Pneumonia in the face of COVID-19. Am J Physiol Lung Cell Mol Physiol 2020;319:L863-6. [PMID: 32996786 DOI: 10.1152/ajplung.00447.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cazzola M, Rogliani P, Aliberti S, Blasi F, Matera MG. An update on the pharmacotherapeutic management of lower respiratory tract infections. Expert Opin Pharmacother 2017;18:973-88. [PMID: 28480770 DOI: 10.1080/14656566.2017.1328497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Bin M Ibrahim I, Pidaparti RM, Ward KR. Evaluation of Ventilation-Induced Lung Inflammation Through Multi-Scale Simulations. IEEE J Transl Eng Health Med 2018;6:1800307. [PMID: 29541555 DOI: 10.1109/JTEHM.2018.2795031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 de Porto AP, Liu Z, de Beer R, Florquin S, de Boer OJ, Hendriks RW, van der Poll T, de Vos AF. Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia. Mol Med 2019;25:3. [PMID: 30646846 DOI: 10.1186/s10020-018-0069-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
7 Chen SH, Tzeng IS, Lan CC, Chen JY, Ng CY, Wang YC, Su WL, Yiang GT, Chen TY, Wu CW, Hsieh PC, Kuo CY, Wu MY. Age, Period and Cohort Analysis of Rates of Emergency Department Visits Due to Pneumonia in Taiwan, 1998-2012. Risk Manag Healthc Policy 2020;13:1459-66. [PMID: 32943963 DOI: 10.2147/RMHP.S255031] [Reference Citation Analysis]
8 Tavares LP, Peh HY, Tan WSD, Pahima H, Maffia P, Tiligada E, Levi-Schaffer F. Granulocyte-targeted therapies for airway diseases. Pharmacol Res 2020;157:104881. [PMID: 32380052 DOI: 10.1016/j.phrs.2020.104881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
9 Letsiou E, Teixeira Alves LG, Felten M, Mitchell TJ, Müller-Redetzky HC, Dudek SM, Witzenrath M. Neutrophil-Derived Extracellular Vesicles Activate Platelets after Pneumolysin Exposure. Cells 2021;10:3581. [PMID: 34944089 DOI: 10.3390/cells10123581] [Reference Citation Analysis]